Fertilization and Implantation

Chapter

Abstract

Knowledge of fertilization and implantation is essential for understanding both normal reproduction and the pathological basis of infertility. The purpose of this chapter is to discuss our current understanding of normal fertilization and implantation. A healthy spermatozoon is essential for reproduction and must undergo a variety of changes in order to fertilize an oocyte. Spermatogenesis occurs in the seminiferous tubules of the testes and is controlled by the affect of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) on testicular Sertoli and Leydig cells. Mature spermatozoa are then transported through the epididymis, combined with seminal vesicle and prostatic secretions, and ultimately transported into the vaginal vault with ejaculation. Through a calcium-mediated process called capacitation, the spermatozoon develop hypermotile flagella and an activated acrosome, eventually resulting in penetration of an oocyte. Normal oogenesis and folliculogenesis are crucial in order to produce a healthy oocyte for fertilization. Following menarche, release of FSH and LH stimulates development of antral follicles, completion of meiosis, and subsequent ovulation of a dominant follicle. An activated spermatozoon binds to the outer layer of the oocyte, the zona pellucid, and fertilization by a single spermatozoa ensues. With completion of a second meiotic division, and genomic union of the sperm and oocyte, a zygote forms. Approximately day 6 or 7 post-ovulation, the trophoectoderm of the blastocyst implants into the endometrial epithelium. Many factors are required for successful implantation. In addition to proper trophoblast development and invasion, endometrial receptivity has been shown to be crucial for normal implantation, and disruption of it a major cause of abnormal placentation and infertility. Due to the complexity of fertilization and implantation, it is not surprising that two of the most common mechanisms of infertility are failure of fertilization and failure of implantation.

Keywords

Cholesterol Permeability Sulfide Heparin Respiration 

References

  1. 1.
    EME. A global perspective on infertility: an under recognized public health issue. Caroline Papers Int Health. 2004;18:1–45.Google Scholar
  2. 2.
    Ombelet W, Cooke I, Dyer S, Serour G, Devroey P. Infertility and the provision of infertility medical services in developing countries. Hum Reprod Update. 2008;14:605–21.PubMedGoogle Scholar
  3. 3.
    Rocha AL, Reis FM, Petraglia F. New trends for the medical treatment of endometriosis. Expert Opin Investig Drugs. 2012;21:905–19.PubMedGoogle Scholar
  4. 4.
    Gerhard F, Weinbauer CML, Manuela Simoni EN. Physiology of testicular function. In: Nieschlag E, Behre HM, Nieschlag S, editors. Andrology: male reproductive health and dysfunction. Berlin, Heidelberg: Springer; 2010.Google Scholar
  5. 5.
    Cornwall GA. New insights into epididymal biology and function. Hum Reprod Update. 2009;15:213–27.PubMedGoogle Scholar
  6. 6.
    Sullivan R, Frenette G, Girouard J. Epididymosomes are involved in the acquisition of new sperm proteins during epididymal transit. Asian J Androl. 2007;9:483–91.PubMedGoogle Scholar
  7. 7.
    Buffone MG, Ijiri TW, Cao W, Merdiushev T, Aghajanian HK, Gerton GL. Heads or tails? Structural events and molecular mechanisms that promote mammalian sperm acrosomal exocytosis and motility. Mol Reprod Dev. 2012;79:4–18.PubMedGoogle Scholar
  8. 8.
    Shum WW, Da Silva N, Brown D, Breton S. Regulation of luminal acidification in the male reproductive tract via cell-cell crosstalk. J Exp Biol. 2009;212:1753–61.PubMedGoogle Scholar
  9. 9.
    Cobellis G, Ricci G, Cacciola G, Orlando P, Petrosino S, Cascio MG, et al. A gradient of 2-arachidonoylglycerol regulates mouse epididymal sperm cell start-up. Biol Reprod. 2010;82:451–8.PubMedGoogle Scholar
  10. 10.
    Dacheux JL, Belghazi M, Lanson Y, Dacheux F. Human epididymal secretome and proteome. Mol Cell Endocrinol. 2006;250:36–42.PubMedGoogle Scholar
  11. 11.
    Hereng TH, Elgstoen KB, Cederkvist FH, Eide L, Jahnsen T, Skålhegg BS, et al. Exogenous pyruvate accelerates glycolysis and promotes capacitation in human spermatozoa. Hum Reprod. 2011;26:3249–63.PubMedGoogle Scholar
  12. 12.
    Rodriguez-Martinez H, Kvist U, Ernerudh J, Sanz L, Calvete JJ. Seminal plasma proteins: what role do they play? Am J Reprod Immunol. 2011;66 Suppl 1Suppl 1:11–22.PubMedGoogle Scholar
  13. 13.
    Lilja H. A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J Clin Invest. 1985;76:1899–903.PubMedGoogle Scholar
  14. 14.
    Bellis MA, Baker RR, Matson P, Chew J. A guide to upwardly mobile spermatozoa. Andrologia. 1990;22:397–9.PubMedGoogle Scholar
  15. 15.
    Suarez SS, Pacey AA. Sperm transport in the female reproductive tract. Hum Reprod Update. 2006;12:23–37.PubMedGoogle Scholar
  16. 16.
    Katz DF, Slade DA, Nakajima ST. Analysis of pre-ovulatory changes in cervical mucus hydration and sperm penetrability. Adv Contracept. 1997;13:143–51.PubMedGoogle Scholar
  17. 17.
    Bigelow JL, Dunson DB, Stanford JB, Ecochard R, Gnoth C, Colombo B. Mucus observations in the fertile window: a better predictor of conception than timing of intercourse. Hum Reprod. 2004;19:889–92.PubMedGoogle Scholar
  18. 18.
    Barros C, Vigil P, Herrera E, Arguello B, Walker R. Selection of morphologically abnormal sperm by human cervical mucus. Arch Androl. 1984;12(Suppl):95–107.PubMedGoogle Scholar
  19. 19.
    Sheehan JK, Oates K, Carlstedt I. Electron microscopy of cervical, gastric and bronchial mucus glycoproteins. Biochem J. 1986;239:147–53.PubMedGoogle Scholar
  20. 20.
    Kunz G, Beil D, Deininger H, Wildt L, Leyendecker G. The dynamics of rapid sperm transport through the female genital tract: evidence from vaginal sonography of uterine peristalsis and hysterosalpingoscintigraphy. Hum Reprod. 1996;11:627–32.PubMedGoogle Scholar
  21. 21.
    Lyons EA, Taylor PJ, Zheng XH, Ballard G, Levi CS, Kredentser JV. Characterization of subendometrial myometrial contractions throughout the menstrual cycle in normal fertile women. Fertil Steril. 1991;55:771–4.PubMedGoogle Scholar
  22. 22.
    Fukuda M, Fukuda K. Uterine endometrial cavity movement and cervical mucus. Hum Reprod. 1994;9:1013–6.PubMedGoogle Scholar
  23. 23.
    Visconti PE, Galantino-Homer H, Moore GD, Bailey JL, Ning X, Fornes M, et al. The molecular basis of sperm capacitation. J Androl. 1998;19:242–8.PubMedGoogle Scholar
  24. 24.
    Visconti PE, Krapf D, de la Vega-Beltran JL, Acevedo JJ, Darszon A. Ion channels, phosphorylation and mammalian sperm capacitation. Asian J Androl. 2011;13:395–405.PubMedGoogle Scholar
  25. 25.
    Suarez SS. Control of hyperactivation in sperm. Hum Reprod Update. 2008;14:647–57.PubMedGoogle Scholar
  26. 26.
    Ho HC, Suarez SS. Characterization of the intracellular calcium store at the base of the sperm flagellum that regulates hyperactivated motility. Biol Reprod. 2003;68:1590–6.PubMedGoogle Scholar
  27. 27.
    Herrick SB, Schweissinger DL, Kim SW, Bayan KR, Mann S, Cardullo RA. The acrosomal vesicle of mouse sperm is a calcium store. J Cell Physiol. 2005;202:663–71.PubMedGoogle Scholar
  28. 28.
    Baker T. A quantitative and cytological study of germ cells in human ovaries. Proc R Soc Lond. 1963;158:417–33.PubMedGoogle Scholar
  29. 29.
    Woods DC, Tilly JL. The next (re)generation of ovarian biology and fertility in women: is current science tomorrow’s practice? Fertil Steril. 2012;98:3–10.PubMedGoogle Scholar
  30. 30.
    Woods DC, White YA, Tilly JL. Purification of oogonial stem cells from adult mouse and human ovaries: an assessment of the literature and a view toward the future. Reprod Sci. 2013;20(1):7–15.PubMedGoogle Scholar
  31. 31.
    Oatley J, Hunt PA. Of mice and (wo)men: purified oogonial stem cells from mouse and human ovaries. Biol Reprod. 2012;86:196.PubMedGoogle Scholar
  32. 32.
    Johnson J, Canning J, Kaneko T, Pru JK, Tilly JL. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature. 2004;428:145–50.PubMedGoogle Scholar
  33. 33.
    Gougeon A, Ecochard R, Thalabard JC. Age-related changes of the population of human ovarian follicles: increase in the disappearance rate of non-growing and early-growing follicles in aging women. Biol Reprod. 1994;50:653–63.PubMedGoogle Scholar
  34. 34.
    Hansen KR, Knowlton NS, Thyer AC, Charleston JS, Soules MR, Klein NA. A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause. Hum Reprod. 2008;23:699–708.PubMedGoogle Scholar
  35. 35.
    Block E. Quantitative morphological investigations of the follicular system in women; variations at different ages. Acta Anat (Basel). 1952;14:108–23.Google Scholar
  36. 36.
    Gougeon A. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr Rev. 1996;17:121–55.PubMedGoogle Scholar
  37. 37.
    Morita Y, Manganaro T, Tao XJ, Martimbeau S, Donahoe PK, Tilly JL. Requirement for phosphatidylinositol-3’-kinase in cytokine mediated germ cell survival during fetal oogenesis in the mouse. Endocrinology. 1999;140(2):941–9.PubMedGoogle Scholar
  38. 38.
    Quennell JH, Stanton JA, Hurst PR. Basic fibroblast growth factor expression in isolated small human ovarian follicles. Mol Hum Reprod. 2004;10(9):623–31.PubMedGoogle Scholar
  39. 39.
    Bedell MA, Brannan CI, Evans EP, Copeland NG, Jenkins NA, Donovan PJ. DNA rearrangements located over 100 kb 5’ of the Steel (Sl)-coding region in Steel-panda and Steel-contrasted mice deregulate Sl expression and cause female sterility by disrupting ovarian follicle development. Gene Dev. 1995;9:455–70.PubMedGoogle Scholar
  40. 40.
    Dean J. Oocyte-specific genes regulate follicle formation, fertility and early mouse development. J Reprod Immunol. 2002;53:171–80.PubMedGoogle Scholar
  41. 41.
    Eric E, Nilsson MKS. Kit ligand and basic fibroblast growth factor interactions in the induction of ovarian primordial to primary follicle transition. Mol Cell Endocrinol. 2004;214:19–25.Google Scholar
  42. 42.
    Muraji M, Sudo T, Iwasaki S, Ueno S, Wakahashi S, Yamaguchi S, et al. The effect of abdominal radical trachelectomy on ovarian reserve: serial changes in serum anti-Müllerian hormone levels. J Cancer. 2012;3:191–5.PubMedGoogle Scholar
  43. 43.
    Craig J, Orisaka M, Wang H, Orisaka S, Thompson W, Zhu C, et al. Gonadotropin and intra-ovarian signals regulating follicle development and atresia: the delicate balance between life and death. Front Biosci. 2007;12:3628–39.PubMedGoogle Scholar
  44. 44.
    Messinis IE. From menarche to regular menstruation: endocrinological background. Ann N Y Acad Sci. 2006;1092:49–56.PubMedGoogle Scholar
  45. 45.
    Gilchrist RB, Lane M, Thompson JG. Oocyte-secreted factors: regulators of cumulus cell function and oocyte quality. Hum Reprod Update. 2008;14:159–77.PubMedGoogle Scholar
  46. 46.
    Drahorad J, Tesarik J, Cechova D, Vilim V. Proteins and glycosaminoglycans in the intercellular matrix of the human cumulus-oophorus and their effect on conversion of proacrosin to acrosin. J Reprod Fertil. 1991;93:253–62.PubMedGoogle Scholar
  47. 47.
    Bedford JM. Site of the mammalian sperm physiological acrosome reaction. PNAS. 2011;108:4703–7.PubMedGoogle Scholar
  48. 48.
    Bleil JD, Wassarman PM. Sperm-egg interactions in the mouse: sequence of events and induction of the acrosome reaction by a zona pellucida glycoprotein. Dev Biol. 1983;95:317–24.PubMedGoogle Scholar
  49. 49.
    Monne M, Jovine L. A structural view of egg coat architecture and function in fertilization. Biol Reprod. 2011;85:661–9.PubMedGoogle Scholar
  50. 50.
    Tremellen K. Oxidative stress and male infertility—a clinical perspective. Hum Reprod Update. 2008;14:243–58.PubMedGoogle Scholar
  51. 51.
    Chen J, Litscher ES, Wassarman PM. Inactivation of the mouse sperm receptor, mZP3, by site-directed mutagenesis of individual serine residues located at the combining site for sperm. Proc Natl Acad Sci USA. 1998;95:6193–7.PubMedGoogle Scholar
  52. 52.
    Jin M, Fujiwara E, Kakiuchi Y, Okabe M, Satouh Y, Baba SA, et al. Most fertilizing mouse spermatozoa begin their acrosome reaction before contact with the zona pellucida during in vitro fertilization. Proc Natl Acad Sci USA. 2011;108:4892–6.PubMedGoogle Scholar
  53. 53.
    Gahlay G, Gauthier L, Baibakov B, Epifano O, Dean J. Gamete recognition in mice depends on the cleavage status of an egg’s zona pellucida protein. Science. 2010;329:216–9.PubMedGoogle Scholar
  54. 54.
    Clark GF. The molecular basis of mouse sperm-zona pellucida binding: a still unresolved issue. Dev Biol Reprod. 2011;142:377–81.Google Scholar
  55. 55.
    Rubinstein E, Ziyyat A, Wolf JP, Le Naour F, Boucheix C. The molecular players of sperm-egg fusion in mammals. Semin Cell Dev Biol. 2006;17:254–63.PubMedGoogle Scholar
  56. 56.
    Evans JP. The molecular basis of sperm-oocyte membrane interactions during mammalian fertilization. Hum Reprod Update. 2002;8:297–311.PubMedGoogle Scholar
  57. 57.
    Nixon B, Aitken RJ, McLaughlin EA. New insights into the molecular mechanisms of sperm-egg interaction. Cell Mol Life Sci. 2007;64:1805–23.PubMedGoogle Scholar
  58. 58.
    Publicover S, Harper CV, Barratt C. [Ca2+]i signalling in sperm–making the most of what you’ve got. Nat Cell Biol. 2007;9:235–42.PubMedGoogle Scholar
  59. 59.
    Swann K, Yu Y. The dynamics of calcium oscillations that activate mammalian eggs. Int J Dev Biol. 2008;52:585–94.PubMedGoogle Scholar
  60. 60.
    Saunders CM, Larman MG, Parrington J, et al. PLC zeta: a sperm-specific trigger of Ca(2+) oscillations in eggs and embryo development. Development. 2002;129:3533–44.PubMedGoogle Scholar
  61. 61.
    Wu AT, Sutovsky P, Xu W, van der Spoel AC, Platt FM, Oko R. The postacrosomal assembly of sperm head protein, PAWP, is independent of acrosome formation and dependent on microtubular manchette transport. Dev Biol. 2007;312:471–83.PubMedGoogle Scholar
  62. 62.
    Kashir J, Heindryckx B, Jones C, De Sutter P, Parrington J, Coward K. Oocyte activation, phospholipase C zeta and human infertility. Hum Reprod Update. 2010;16:690–703.PubMedGoogle Scholar
  63. 63.
    Payne C, Rawe V, Ramalho-Santos J, Simerly C, Schatten G. Preferentially localized dynein and perinuclear dynactin associate with nuclear pore complex proteins to mediate genomic union during mammalian fertilization. J Cell Sci. 2003;116:4727–38.PubMedGoogle Scholar
  64. 64.
    Watson AJ. The cell biology of blastocyst development. Mol Reprod Dev. 1992;33:492–504.PubMedGoogle Scholar
  65. 65.
    Capco DG. Molecular and biochemical regulation of early mammalian development. Int Rev Cytol. 2001;207:195–235.PubMedGoogle Scholar
  66. 66.
    Perona RM, Wassarman PM. Mouse blastocysts hatch in vitro by using a trypsin-like proteinase associated with cells of mural trophectoderm. Dev Biol. 1986;114:42–52.PubMedGoogle Scholar
  67. 67.
    Menino Jr AR, O’Claray JL. Enhancement of hatching and trophoblastic outgrowth by mouse embryos cultured in Whitten’s medium containing plasmin and plasminogen. J Reprod Fertil. 1986;77:159–67.PubMedGoogle Scholar
  68. 68.
    Huppertz B, Berghold VM, Kawaguchi R, Gauster M. A variety of opportunities for immune interactions during trophoblast development and invasion. Am J Reprod Immunol. 2012;67:349–57.PubMedGoogle Scholar
  69. 69.
    Huppertz B, Bartz C, Kokozidou M. Trophoblast fusion: fusogenic proteins, syncytins and ADAMs, and other prerequisites for syncytial fusion. Micron. 2006;37:509–17.PubMedGoogle Scholar
  70. 70.
    Muhlhauser J, Crescimanno C, Kaufmann P, Hofler H, Zaccheo D, Castellucci M. Differentiation and proliferation patterns in human trophoblast revealed by c-erbB-2 oncogene product and EGF-R. J Histochem Cytochem. 1993;41:165–73.PubMedGoogle Scholar
  71. 71.
    Irving JA, Lala PK. Functional role of cell surface integrins on human trophoblast cell migration: regulation by TGF-beta, IGF-II, and IGFBP-1. Exp Cell Res. 1995;217:419–27.PubMedGoogle Scholar
  72. 72.
    Isaka K, Usuda S, Ito H, et al. Expression and activity of matrix metalloproteinase 2 and 9 in human trophoblasts. Placenta. 2003;24:53–64.PubMedGoogle Scholar
  73. 73.
    Librach CL, Werb Z, Fitzgerald ML, Chiu K, Corwin NM, Esteves RA, et al. 92-kD type IV collagenase mediates invasion of human cytotrophoblasts. J Cell Biol. 1991;113:437–49.PubMedGoogle Scholar
  74. 74.
    Stetler-Stevenson WG, Krutzsch HC, Liotta LA. Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. J Biol Chem. 1989;264:17374–8.PubMedGoogle Scholar
  75. 75.
    Hurskainen T, Hoyhtya M, Tuuttila A, Oikarinen A, Autio-Harmainen H. mRNA expressions of TIMP-1, -2, and -3 and 92-KD type IV collagenase in early human placenta and decidual membrane as studied by in situ hybridization. J Histochem Cytochem. 1996;44:1379–88.PubMedGoogle Scholar
  76. 76.
    Staun-Ram E, Shalev E. Human trophoblast function during the implantation process. Reprod Biol Endocrinol. 2005;3:56.PubMedGoogle Scholar
  77. 77.
    Zhang X, Green KE, Yallampalli C, Dong YL. Adrenomedullin enhances invasion by trophoblast cell lines. Biol Reprod. 2005;73:619–26.PubMedGoogle Scholar
  78. 78.
    Chung IB, Yelian FD, Zaher FM, Gonik B, Evans MI, Diamond MP, et al. Expression and regulation of vascular endothelial growth factor in a first trimester trophoblast cell line. Placenta. 2000;21:320–4.PubMedGoogle Scholar
  79. 79.
    Trundley A, Moffett A. Human uterine leukocytes and pregnancy. Tissue Antigens. 2004;63:1–12.PubMedGoogle Scholar
  80. 80.
    A morphological analysis of the early implantation stages in the rat. Am J Anat. 1967;125:1–29.Google Scholar
  81. 81.
    Cakmak H, Taylor HS. Implantation failure: molecular mechanisms and clinical treatment. Hum Reprod Update. 2011;17:242–53.PubMedGoogle Scholar
  82. 82.
    Wilcox AJ, Baird DD, Weinberg CR. Time of implantation of the conceptus and loss of pregnancy. N Engl J Med. 1999;340:1796–9.PubMedGoogle Scholar
  83. 83.
    Alok Sharma PK. Understanding implantation window, a crucial phenomenon. J Hum Reprod Sci. 2012;5:2–6.PubMedGoogle Scholar
  84. 84.
    Usadi RS, Murray MJ, Bagnell RC, Fritz MA, Kowalik AI, Meyer WR, et al. Temporal and morphologic characteristics of pinopod expression across the secretory phase of the endometrial cycle in normally cycling women with proven fertility. Fertil Steril. 2003;79:970–4.PubMedGoogle Scholar
  85. 85.
    Achache H, Revel A. Endometrial receptivity markers, the journey to successful embryo implantation. Hum Reprod Update. 2006;12:731–46.PubMedGoogle Scholar
  86. 86.
    Aghajanova L, Stavreus-Evers A, Nikas Y, Hovatta O, Landgren BM. Coexpression of pinopodes and leukemia inhibitory factor, as well as its receptor, in human endometrium. Fertil Steril. 2003;79 Suppl 1Suppl 1:808–14.PubMedGoogle Scholar
  87. 87.
    Lessey BA, Damjanovich L, Coutifaris C, Castelbaum A, Albelda SM, Buck CA. Integrin adhesion molecules in the human endometrium. Correlation with the normal and abnormal menstrual cycle. J Clin Invest. 1992;90:188–95.PubMedGoogle Scholar
  88. 88.
    Genbacev OD, Prakobphol A, Foulk RA, Krtolica AR, Ilic D, Singer MS, et al. Trophoblast L-selectin-mediated adhesion at the maternal-fetal interface. Science. 2003;299:405–8.PubMedGoogle Scholar
  89. 89.
    Lai TH, Shih Ie M, Vlahos N, Ho CL, Wallach E, Zhao Y. Differential expression of L-selectin ligand in the endometrium during the menstrual cycle. Fertil Steril. 2005;83 Suppl 1Suppl 1:1297–302.PubMedGoogle Scholar
  90. 90.
    Fazleabas AT, Kim JJ. Development. What makes an embryo stick? Science. 2003;299:355–6.PubMedGoogle Scholar
  91. 91.
    Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell. 2002;110:673–87.PubMedGoogle Scholar
  92. 92.
    Lessey BA. Two pathways of progesterone action in the human endometrium: implications for implantation and contraception. Steroids. 2003;68:809–15.PubMedGoogle Scholar
  93. 93.
    Apparao KB, Lovely LP, Gui Y, Lininger RA, Lessey BA. Elevated endometrial androgen receptor expression in women with polycystic ovarian syndrome. Biol Reprod. 2002;66:297–304.PubMedGoogle Scholar
  94. 94.
    Daftary GS, Troy PJ, Bagot CN, Young SL, Taylor HS. Direct regulation of beta3-integrin subunit gene expression by HOXA10 in endometrial cells. Mol Endocrinol. 2002;16:571–9.PubMedGoogle Scholar
  95. 95.
    Thomas K, Thomson A, Wood S, Kingsland C, Vince G, Lewis-Jones I. Endometrial integrin expression in women undergoing in vitro fertilization and the association with subsequent treatment outcome. Fertil Steril. 2003;80:502–7.PubMedGoogle Scholar
  96. 96.
    Carson DD. The glycobiology of implantation. Front Biosci. 2002;7:d1535–44.PubMedGoogle Scholar
  97. 97.
    Aplin JD. MUC-1 glycosylation in endometrium: possible roles of the apical glycocalyx at implantation. Hum Reprod. 1999;14 Suppl 2Suppl. 2:17–25.PubMedGoogle Scholar
  98. 98.
    Thathiah A, Carson DD. MT1-MMP mediates MUC1 shedding independent of TACE/ADAM17. Biochem J. 2004;382:363–73.PubMedGoogle Scholar
  99. 99.
    Aplin JD, Hey NA, Graham RA. Human endometrial MUC1 carries keratan sulfate: characteristic glycoforms in the luminal epithelium at receptivity. Glycobiology. 1998;8:269–76.PubMedGoogle Scholar
  100. 100.
    Carson DD, William J. Lennarz, M. Daniel Lane. Mucins in embryo implantation. In: Encyclopedia of biological chemistry. Philadelphia: Elsevier; 2004.Google Scholar
  101. 101.
    Serle E, Aplin JD, Li TC, Warren MA, Graham RA, Seif MW, et al. Endometrial differentiation in the peri-implantation phase of women with recurrent miscarriage: a morphological and immunohistochemical study. Fertil Steril. 1994;62:989–96.PubMedGoogle Scholar
  102. 102.
    Dimitriadis E, White CA, Jones RL, Salamonsen LA. Cytokines, chemokines and growth factors in endometrium related to implantation. Hum Reprod Update. 2005;11:613–30.PubMedGoogle Scholar
  103. 103.
    Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Köntgen F, et al. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature. 1992;359:76–9.PubMedGoogle Scholar
  104. 104.
    Stewart CL. Leukaemia inhibitory factor and the regulation of pre-implantation development of the mammalian embryo. Mol Reprod Dev. 1994;39:233–8.PubMedGoogle Scholar
  105. 105.
    Arici A, Engin O, Attar E, Olive DL. Modulation of leukemia inhibitory factor gene expression and protein biosynthesis in human endometrium. J Clin Endocrinol Metab. 1995;80:1908–15.PubMedGoogle Scholar
  106. 106.
    Sharkey AM, King A, Clark DE, Burrows TD, Jokhi PP, Charnock-Jones DS, et al. Localization of leukemia inhibitory factor and its receptor in human placenta throughout pregnancy. Biol Reprod. 1999;60:355–64.PubMedGoogle Scholar
  107. 107.
    Gemzell Danielsson K. MLSaMB. he effect of various doses of mifepristone on endometrial leukaemia inhibitory factor expression in the midluteal phase—an immunohistochemical study. Hum Reprod. 1997;12:1293–7.Google Scholar
  108. 108.
    Perrier d’Hauterive S, Charlet-Renard C, Berndt S, Dubois M, Munaut C, Goffin F, et al. Human chorionic gonadotropin and growth factors at the embryonic-endometrial interface control leukemia inhibitory factor (LIF) and interleukin 6 (IL-6) secretion by human endometrial epithelium. Hum Reprod. 2004;19:2633–43.PubMedGoogle Scholar
  109. 109.
    Ledee-Bataille N, Lapree-Delage G, Taupin JL, Dubanchet S, Frydman R, Chaouat G. Concentration of leukaemia inhibitory factor (LIF) in uterine flushing fluid is highly predictive of embryo implantation. Hum Reprod. 2002;17:213–8.PubMedGoogle Scholar
  110. 110.
    Mikolajczyk M, Skrzypczak J, Szymanowski K, Wirstlein P. The assessment of LIF in uterine flushing–a possible new diagnostic tool in states of impaired fertility. Reprod Biol. 2003;3:259–70.PubMedGoogle Scholar
  111. 111.
    Laird SM, Tuckerman EM, Dalton CF, Dunphy BC, Li TC, Zhang X. The production of leukaemia inhibitory factor by human endometrium: presence in uterine flushings and production by cells in culture. Hum Reprod. 1997;12:569–74.PubMedGoogle Scholar
  112. 112.
    Brinsden PR, Ndukwe G, Engrand P, Pinkstone S, Lancaster S, Macnamee MC, et al. Does recombinant human leukemia inhibitory factor improve implantation in women with recurrent failure of assisted reproduction treatment? [Abstract]. In: 19th Annual meeting of the European Society for human reproduction and embryology, Madrid, Spain; 2003.Google Scholar
  113. 113.
    Simon C, Gimeno MJ, Mercader A, O’Connor JE, Remohí J, Polan ML, et al. Embryonic regulation of integrins beta 3, alpha 4, and alpha 1 in human endometrial epithelial cells in vitro. J Clin Endocrinol Metab. 1997;82:2607–16.PubMedGoogle Scholar
  114. 114.
    Boucher A, Kharfi A, Al-Akoum M, Bossu P, Akoum A. Cycle-dependent expression of interleukin-1 receptor type II in the human endometrium. Biol Reprod. 2001;65:890–8.PubMedGoogle Scholar
  115. 115.
    Simon C, Frances A, Piquette GN, el Danasouri I, Zurawski G, Dang W, et al. Embryonic implantation in mice is blocked by interleukin-1 receptor antagonist. Endocrinology. 1994;134: 521–8.PubMedGoogle Scholar
  116. 116.
    Tabibzadeh S, Kong QF, Babaknia A, May LT. Progressive rise in the expression of interleukin-6 in human endometrium during menstrual cycle is initiated during the implantation window. Hum Reprod. 1995;10:2793–9.PubMedGoogle Scholar
  117. 117.
    Robertson SA. OCAaRA. The effect of interleukin-6 deficiency of implantation, fetal development and parturation in mice. Proc Aust Soc. Reprod Biol. 2000;31:97.Google Scholar
  118. 118.
    Salamonsen LA, Dimitriadis E, Robb L. Cytokines in implantation. Semin Reprod Med. 2000;18:299–310.PubMedGoogle Scholar
  119. 119.
    von Wolff M, Thaler CJ, Strowitzki T, Broome J, Stolz W, Tabibzadeh S. Regulated expression of cytokines in human endometrium throughout the menstrual cycle: dysregulation in habitual abortion. Mol Hum Reprod. 2000;6:627–34.Google Scholar
  120. 120.
    von Rango U, Alfer J, Kertschanska S, Kemp B, Müller-Newen G, Heinrich PC, et al. Interleukin-11 expression: its significance in eutopic and ectopic human implantation. Mol Hum Reprod. 2004;10:783–92.Google Scholar
  121. 121.
    Song H, Lim H, Paria BC, et al. Cytosolic phospholipase A2alpha is crucial [correction of A2alpha deficiency is crucial] for ‘on-time’ embryo implantation that directs subsequent development. Development. 2002;129:2879–89.PubMedGoogle Scholar
  122. 122.
    Cakmak H, Taylor HS. Molecular mechanisms of treatment resistance in endometriosis: the role of progesterone-hox gene interactions. Semin Reprod Med. 2010;28:69–74.PubMedGoogle Scholar
  123. 123.
    Taylor HS, Arici A, Olive D, Igarashi P. HOXA10 is expressed in response to sex steroids at the time of implantation in the human endometrium. J Clin Invest. 1998;101:1379–84.PubMedGoogle Scholar
  124. 124.
    Benson GV, Lim H, Paria BC, Satokata I, Dey SK, Maas RL. Mechanisms of reduced fertility in Hoxa-10 mutant mice: uterine homeosis and loss of maternal Hoxa-10 expression. Development. 1996;122:2687–96.PubMedGoogle Scholar
  125. 125.
    Taylor HS, Bagot C, Kardana A, Olive D, Arici A. HOX gene expression is altered in the endometrium of women with endometriosis. Hum Reprod. 1999;14:1328–31.PubMedGoogle Scholar
  126. 126.
    Cermik D, Selam B, Taylor HS. Regulation of HOXA-10 expression by testosterone in vitro and in the endometrium of patients with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003;88:238–43.PubMedGoogle Scholar
  127. 127.
    Daftary GS, Kayisli U, Seli E, Bukulmez O, Arici A, Taylor HS. Salpingectomy increases peri-implantation endometrial HOXA10 expression in women with hydrosalpinx. Fertil Steril. 2007;87:367–72.PubMedGoogle Scholar
  128. 128.
    King A, Allan DS, Bowen M, Powis SJ, Joseph S, Verma S, et al. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells. Eur J Immunol. 2000;30:1623–31.PubMedGoogle Scholar
  129. 129.
    Fukui A, Fujii S, Yamaguchi E, Kimura H, Sato S, Saito Y. Natural killer cell subpopulations and cytotoxicity for infertile patients undergoing in vitro fertilization. Am J Reprod Immunol. 1999;41:413–22.PubMedGoogle Scholar
  130. 130.
    Fukui A, Funamizu A, Yokota M, Yamada K, Nakamua R, Fukuhara R, et al. Uterine and circulating natural killer cells and their roles in women with recurrent pregnancy loss, implantation failure and preeclampsia. J Reprod Immunol. 2011;90:105–10.PubMedGoogle Scholar
  131. 131.
    Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril. 2012.Google Scholar
  132. 132.
    Assisted reproductive technology in the United States: 2001 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology registry. Fertil Steril. 2007;87:1253–66.Google Scholar
  133. 133.
    Rodriguez-Wallberg KA, Oktay K. Options on fertility preservation in female cancer patients. Cancer Treat Rev. 2012;38:354–61.PubMedGoogle Scholar
  134. 134.
    Donaghay M, Lessey BA. Uterine receptivity: alterations associated with benign gynecological disease. Semin Reprod Med. 2007;25:461–75.PubMedGoogle Scholar
  135. 135.
    Lessey BA. Assessment of endometrial receptivity. Fertil Steril. 2011;96:522–9.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of Obstetrics and GynecologyYale School of MedicineNew HavenUSA

Personalised recommendations